Research 'brings new hope' to type-1-diabetes patients

Its hoped new research into type-1-diabetes could spell an end to patients' life-long need for daily needle treatment.Scientists have identified a crucial hybrid peptide that could unlock the mystery of why the immune system kills insulin-producing cells.